Pelican Diagnostics

Pelican Diagnostics is a private medical diagnostics company focused on rapid, point-of-care testing using saliva and other bodily-fluid samples. The company has described a handheld reusable digital reader with disposable cartridges designed to detect infectious disease targets directly from saliva, and in 2021 announced CE Mark clearance for a COVID-19 saliva test in Europe. Public trademark and patent records also indicate broader ambitions in molecular detection, including devices for detecting DNA, RNA, immunological disorders, and volatile organic compounds. Pelican appears to operate as a diagnostics/device developer rather than a therapeutics company, with its core proposition centered on ultra-rapid, non-invasive testing and connected digital screening workflows.